Reply to MOH queries

Reply to MOH queries Many businesses, large and small, have a huge source of great ideas that can help them improve, innovate, and grow, and yet so many of these companies never think of using this amazing corporate asset. What is this highly valuable asset? Its own people. Says Morgan Fraud, the author of The… Continue reading Reply to MOH queries

Clinical and non-clinical overviews

Clinical and non-clinical overviews The new wordpress theme called Consulting WP has been lauded by critics for its presentation. The theme is made by Style Mix Themes, who have been key players in the theme industry for a long time. People were excited to see what they would come up with next; their specialty has… Continue reading Clinical and non-clinical overviews

Export Dossier Documents

Export Dossier Documents Many businesses, large and small, have a huge source of great ideas that can help them improve, innovate, and grow, and yet so many of these companies never think of using this amazing corporate asset. What is this highly valuable asset? Its own people. Says Morgan Fraud, the author of The Thinking… Continue reading Export Dossier Documents

International Regulatory Registration

International Regulatory Registration Many businesses, large and small, have a huge source of great ideas that can help them improve, innovate, and grow, and yet so many of these companies never think of using this amazing corporate asset. What is this highly valuable asset? Its own people. Says Morgan Fraud, the author of The Thinking… Continue reading International Regulatory Registration

Pre-submission compilation and checking

Pre-submission compilation and checking The new wordpress theme called Consulting WP has been lauded by critics for its presentation. The theme is made by Style Mix Themes, who have been key players in the theme industry for a long time. People were excited to see what they would come up with next; their specialty has… Continue reading Pre-submission compilation and checking

Lupin recalls 12,480 bottles of anti-depressant drug from US.

Lupin recalls 12,480 bottles of anti-depressant drug from US. NEW DELHI: Drug firm Lupin’s US arm, Lupin Pharmaceuticals Inc, is recalling 12,480 bottles of Paroxetine extended-release tablets on account of failed dissolution specifications from the US market. Lupin Pharmaceuticals Inc is recalling 12,480 bottles of Paroxetine extended-release tablets in the strength of 12.5 mg manufactured… Continue reading Lupin recalls 12,480 bottles of anti-depressant drug from US.

Zydus Cadila launches anti-ulcer drug in US.

Zydus Cadila launches anti-ulcer drug in US. NEW DELHI: Zydus Cadila has launched mesalamine delayed release tablets, used for the treatment of ulcerative colitis, in the US market. “Zydus CadilaBSE -1.00 % has commercially launched its mesalamine delayed release tablets in the US market. ZydusBSE 0.68 % was the first to file an Abbreviated New… Continue reading Zydus Cadila launches anti-ulcer drug in US.

To fight China monopoly, Indian Govt to approve for 4 mega bulk drugs parks

To fight China monopoly, Indian Govt to approve for 4 mega bulk drugs parks New Delhi: The Indian Government has decided to hasten the approvals for mega bulk drugs parks in the country to counter the China’s dominance in the sector. Bulk drugs, also known as active pharmaceutical ingredients (API), are the raw materials for the… Continue reading To fight China monopoly, Indian Govt to approve for 4 mega bulk drugs parks

The U.S. Food and Drug Administration approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in adults.

The U.S. Food and Drug Administration approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in adults. The U.S. Food and Drug Administration approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in adults.

The U.S. Food and Drug Administration issued a draft guidance which, once finalized, will assist cosmetics companies submitting cosmetic product facility registrations and cosmetic product listings, including ingredients, to the FDA.

The U.S. Food and Drug Administration issued a draft guidance which, once finalized, will assist cosmetics companies submitting cosmetic product facility registrations and cosmetic product listings, including ingredients, to the FDA. The U.S. Food and Drug Administration issued a draft guidance which, once finalized, will assist cosmetics companies submitting cosmetic product facility registrations and cosmetic… Continue reading The U.S. Food and Drug Administration issued a draft guidance which, once finalized, will assist cosmetics companies submitting cosmetic product facility registrations and cosmetic product listings, including ingredients, to the FDA.